PUMA

academical publication management
collect, organize, and share publications

( en | de )

 

Disambiguation of "Rau, Alexander"

Author of the publication

copydeleteadd this publication to your clipboard
Dual- and triple-targeting of the HER-family members using combinations of mono- and bispecific antibodies

. Universität Stuttgart, Stuttgart, Dissertation, (2023)
DOI: 10.18419/opus-13872

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Lothar Rau University of Stuttgart

Dr. -Ing. Thomas Rauscher University of Stuttgart

Sarah Rauschert University of Stuttgart

Tobias Rau University of Stuttgart

Simeon Rau University of Stuttgart

 

Other publications of authors with the same name

Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IV, , , , , , , , , and 1 other author(s). mAbs, 9 (5): 831-843 (2017)Inhibition of Tumor Cell Growth and Cancer Stem Cell Expansion by a Bispecific Antibody Targeting EGFR and HER3, , , , , , , , and . Molecular Cancer Therapeutics, 19 (7): 1474-1485 (2020)Diabody-Ig: a novel platform for the generation of multivalent and multispecific antibody molecules, , , , and . mAbs, 11 (5): 919-929 (2019)A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3, , , , , , , , , and 1 other author(s). mAbs, 13 (1): 1902034 (2021)Triple targeting of HER receptors overcomes heregulin-mediated resistance to EGFR blockade in colorectal cancerTriple HER blockade in CRC, , , , , , , , , and 2 other author(s). Molecular Cancer Therapeutics, (2022)Dual- and triple-targeting of the HER-family members using combinations of mono- and bispecific antibodies. Universität Stuttgart, Stuttgart, Dissertation, (2023)Patient-derived colonic organoids as a model to study pharmacogenetics, , , , , , , , , and 1 other author(s). 392, 1, page S54. Berlin, Springer, (2019)Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IV, , , , , , , , , and 1 other author(s). mAbs, 9 (5): 831--843 (July 2017)